$96.06
-2.60-2.64%
가까이에: Sep 18, 5:00 PM EST
$97.00
0.940.98%
시간외: Sep 18, 4:47 PM EST
Benzinga
Benzinga
Benzinga
일요일, 9월 20
BioNTech SE
BNTXNASDAQ
BioNTech Earnings & Forecasts
BioNTech (BNTX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
BioNTech Guidance
BioNTech (BNTX)는 8월 4, 2026에 fiscal year 2026에 대한 가이던스를 마지막으로 발표했습니다. 회사는 해당 기간의 매출을 $1.86B - $2.21B 범위로 예상했습니다.
이전 가이던스와 비교하여 BioNTech는 매출 전망치를 이전 범위인 하향 조정됨에서 $2.33B - $2.68B로 상향 조정했습니다.
BioNTech은 13과 1월 9, 2024 사이에 8월 4, 2026개의 지침 업데이트를 발표했습니다. During this period, the company raised its outlook 1 time and lowered it 6 times, providing investors with insight into management's evolving expectations.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-2.34 | $-2.52 | $-0.47 | $0.75 |
| Actual | $-2.58 | $-2.28 | $-0.38 | $-0.14 |
| Surprise | -10.3% | +9.52% | +19.1% | -118.7% |
| Revenue | ||||
| Estimate | $182.0M | $214.6M | $889.5M | $1.19B |
| Actual | $122.8M | $138.0M | $1.06B | $1.78B |
| Surprise | -32.6% | -35.7% | +18.7% | +49.2% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E |
|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||
| Consensus | $1.00 | $-1.34 | $-2.66 |
| Revenue | |||
| Consensus | $1.21B | $688.4M | — |
Earnings & Guidance News
Benzinga
© 2026 Benzinga | All Rights Reserved